IRIS
CRIMI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.441
AS - Asia 4.729
EU - Europa 2.637
SA - Sud America 581
AF - Africa 452
Continente sconosciuto - Info sul continente non disponibili 232
OC - Oceania 5
Totale 14.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.261
SG - Singapore 1.930
CN - Cina 1.523
RU - Federazione Russa 986
IT - Italia 799
BR - Brasile 475
KR - Corea 474
VN - Vietnam 242
IE - Irlanda 239
BD - Bangladesh 208
FR - Francia 183
CI - Costa d'Avorio 161
CA - Canada 101
NG - Nigeria 99
GB - Regno Unito 88
IN - India 77
BJ - Benin 55
FI - Finlandia 54
NL - Olanda 51
DE - Germania 47
SN - Senegal 44
AR - Argentina 43
MX - Messico 38
JP - Giappone 34
ZA - Sudafrica 34
IQ - Iraq 32
UA - Ucraina 32
IR - Iran 29
PL - Polonia 29
TR - Turchia 28
KE - Kenya 26
SE - Svezia 25
ES - Italia 24
HK - Hong Kong 24
CO - Colombia 16
EC - Ecuador 15
PK - Pakistan 14
AT - Austria 12
ID - Indonesia 12
GR - Grecia 11
MA - Marocco 11
MY - Malesia 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
VE - Venezuela 10
JO - Giordania 9
SA - Arabia Saudita 9
AZ - Azerbaigian 7
CH - Svizzera 7
UZ - Uzbekistan 7
BE - Belgio 6
CL - Cile 6
ET - Etiopia 6
JM - Giamaica 6
NP - Nepal 6
PT - Portogallo 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
EG - Egitto 5
GT - Guatemala 5
IL - Israele 5
KZ - Kazakistan 5
PE - Perù 5
AU - Australia 4
DZ - Algeria 4
HU - Ungheria 4
OM - Oman 4
TN - Tunisia 4
BB - Barbados 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
SI - Slovenia 3
SV - El Salvador 3
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
KG - Kirghizistan 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
KW - Kuwait 1
Totale 13.836
Salva come PNG Salva come JPEG
Città #
Dallas 1.296
Singapore 1.146
Hefei 824
Santa Clara 799
San Jose 514
Seoul 471
Ashburn 402
Moscow 377
Dublin 239
Chicago 201
Los Angeles 185
Boardman 178
Abidjan 161
Beijing 159
Lauterbourg 153
Council Bluffs 116
Chandler 100
Catania 91
New York 88
Ho Chi Minh City 82
Milan 77
Civitanova Marche 66
Buffalo 61
Lagos 60
São Paulo 60
Hanoi 58
Rome 58
Cotonou 55
Palermo 46
Dakar 44
Lappeenranta 44
Orem 37
Abuja 35
Jacksonville 35
Brooklyn 28
Johannesburg 27
Toronto 27
Montreal 26
Amsterdam 25
Tokyo 25
Warsaw 24
Pune 23
Tehran 23
Atlanta 22
Seattle 22
Lawrence 19
Andover 18
Cambridge 18
Hong Kong 18
Phoenix 17
Rio de Janeiro 17
San Francisco 16
Chennai 15
Manchester 15
Poplar 15
Des Moines 14
Frankfurt am Main 13
Houston 13
Nanjing 13
Naples 13
Ankara 12
Bologna 12
Denver 12
Stockholm 12
Bari 11
Kochi 11
Turin 11
Boston 10
Da Nang 10
London 10
Messina 10
Mexico City 10
Salvador 10
Bremen 9
Dhaka 9
Dong Ket 9
Giarre 9
Wilmington 9
Belo Horizonte 8
Paris 8
Reggio Emilia 8
Secaucus 8
Amman 7
Baghdad 7
Brasília 7
Campinas 7
Charlotte 7
Fortaleza 7
Haiphong 7
Helsinki 7
Las Vegas 7
Mumbai 7
Munich 7
Praia Grande 7
Ribeirão Preto 7
Rimini 7
Shenyang 7
The Bronx 7
Aci Catena 6
Assago 6
Totale 9.166
Salva come PNG Salva come JPEG
Nome #
Practice of oxygenation and respiratory support during fibreoptic bronchoscopy: the OxyFOB study protocol 403
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 149
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer 144
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction 140
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 137
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 134
Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review 133
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 132
Rugarli. Medicina interna sistematica 131
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 128
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 128
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 126
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 125
Bronchodilator response as a marker of poor asthma control 124
Protective effect of Resveratrol on TGF-beta-induced lung fibroblast differentiation 124
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 123
Asthma severity: the patient’s point of view 121
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 120
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 119
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 118
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 115
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies 113
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation 112
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 112
Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI) 111
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort 111
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 111
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics 110
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients 109
Diastolic Function and Positive Airway Pressure: More Research Is Warranted 108
A European survey of Non- Invasive Ventilation (NIV) 108
Adherence to omalizumab: A multicenter "real-world" study 107
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report 107
Continuous vs intermittent Non-Invasive blood pressure MONitoring in preventing postoperative organ failure (niMON): study protocol for an open-label, multicenter randomized trial 106
Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease 105
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 104
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 104
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 103
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 102
Mutual Interaction Between Human Lung Fibroblasts And T LymphocyteS 102
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 101
Intermittent abdominal pressure ventilation management in neuromuscular diseases: a Delphi panel Consensus 99
Diagnostic delay in bronchiectasis: an Italian perspective 99
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells 98
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy 98
Impact of asthma on bronchiectasis severity and risk of exacerbations 98
Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 97
Personalized Medicine in Asthma: Current Approach and Future Perspectives 97
Are we overlooking the lung function in the definition of severe asthma remission? 97
A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There? 97
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 97
Exhaled breath condensate cysteinyl leukotrienes (cys-LTs) in gastroesophageal reflux disease-related asthma 96
The Link between Asthma and Bronchiectasis: State of the Art 94
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume? 92
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 92
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 91
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 90
Effects of high-flow nasal therapy on swallowing function: a scoping review 89
Airway hyperresponsiveness with chest strapping: effects of heterogeneity and reduced lung volume 88
“The Kafka’s Disease” 87
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 86
Biologics in severe asthma 86
Point-of-care blood eosinophil count in a severe asthma clinic setting 86
Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD? 85
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis 84
Secretion management in patients with ineffective airway clearance with non-invasive mechanical ventilation use: Expert guidance for clinical practice 83
A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY) 83
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 82
Tezepelumab for asthma 82
Bronchial reversibility testing: an index of poorly controlled asthma 82
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 82
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma 81
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 81
Comparability of asthma control test scores between self and physician-administered test 81
Prolonged respiratory failure: when doctor and family connect, the patient wins 80
Effectiveness of an educational intervention on different types of errors ­occurring during inhaler therapy use in COPD patients during a ­Pulmonary Rehabilitation Program 80
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension 80
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 80
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 79
Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure 78
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up 78
A new gambler at the table of management of COVID-19 associated acute respiratory failure. Changing position to do it better? 78
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 77
Impact of chronic obstructive pulmonary disease on passive viscoelastic components of the musculoarticular system 77
Noninvasive respiratory support in acute hypoxemic respiratory failure associated with COVID-19 and other viral infections 76
Domiciliary Non-invasive Ventilation in COPD: An International Survey of Indications and Practices 74
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate 73
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 73
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 73
Fully covered self-expandable metal stent (SEMS) in tracheo-bronchial disorders: clinical experience 72
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 72
Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis 71
Long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases: The Italian snapshot 70
Can humidified high flow reverse mucus plugging? 70
REINVENT: ERS International survey on REstrictive thoracic diseases IN long term home noninvasive VENTilation 69
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask 69
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 69
Uneven use of noninvasive ventilation in acute respiratory failure in Europe 68
Incidence and diagnosis of HIT in patients undergoing thoracoabdominal aortic aneurysm (TAA) repair 68
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future 68
Totale 10.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022114 0 20 0 2 17 0 20 2 14 2 3 34
2022/2023632 19 11 8 44 23 50 49 115 246 19 19 29
2023/2024689 24 78 40 59 29 125 16 69 7 34 134 74
2024/20253.385 69 452 223 109 614 373 131 83 225 302 306 498
2025/20268.691 589 1.124 1.506 465 1.041 1.271 863 215 379 485 462 291
2026/2027351 314 37 0 0 0 0 0 0 0 0 0 0
Totale 14.077